Register entry
- Registered sites
- 0
- Active NDC listings
- 8
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: ANDA 5, NDA AUTHORIZED GENERIC 2, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection, solution | 7 |
| gel | 1 |
| Route | NDCs |
|---|---|
| submucosal | 7 |
| periodontal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| dentsply pharmaceutical | 6 |
| dentsply pharmaceutical inc. | 2 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Articadent | Articaine hydrochloride and Epinephrine Bitartrate | injection, solution, submucosal | 66312-601NDA AUTHORIZED GENERIC |
| Articadent | Articaine hydrochloride and Epinephrine Bitartrate | injection, solution, submucosal | 66312-602NDA AUTHORIZED GENERIC |
| Citanest Forte DENTAL | prilocaine hcl and epinephrine | injection, solution, submucosal | 66312-580ANDA |
| Citanest Plain | prilocaine hydrochloride | injection, solution, submucosal | 66312-630ANDA |
| Oraqix | lidocaine and prilocaine | gel, periodontal | 66312-110NDA |
| Polocaine | Mepivacaine Hydrochloride | injection, solution, submucosal | 66312-441ANDA |
| Xylocaine | Lidocaine Hydrochloride and Epinephrine Bitartrate | injection, solution, submucosal | 66312-176ANDA |
| Xylocaine | Lidocaine Hydrochloride and Epinephrine Bitartrate | injection, solution, submucosal | 66312-181ANDA |
Enquiry
Common questions
- Is Dentsply Pharmaceutical Inc. FDA approved?
- Dentsply Pharmaceutical Inc. holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Dentsply Pharmaceutical Inc. make?
- 8 products are listed under Dentsply Pharmaceutical Inc. in the openFDA NDC Directory, most often as injection, solution; gel. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.